[EN] QUINOLINE DERIVATIVES WITH AFFINITY FOR THE 5-HT2B RECEPTOR<br/>[FR] DÉRIVÉS DE QUINOLINE AYANT UNE AFFINITÉ POUR LE RÉCEPTEUR 5-HT2B
申请人:GLAXO GROUP LTD
公开号:WO2009080675A1
公开(公告)日:2009-07-02
The present invention relates to 8-[4-(1,1 -dioxidotetrahydro-2H-thiopyran-4-yl)-1- piperazinyl]-2-methylquinoline or a pharmaceutically acceptable salt thereof (compounds of formula (I)) which bind to the 5-HT2B receptor and are capable of interfering with the effects of 5-hydroxytryptamine (5-HT) at the 5-HT2B receptor; to pharmaceutical compositions containing them; and to the use of such compounds in therapy.